CRIS Current Research Information System

FANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.256
AS - Asia 28.307
EU - Europa 23.946
SA - Sud America 1.913
AF - Africa 1.857
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 11
Totale 90.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.939
SG - Singapore 8.531
CN - Cina 8.267
GB - Regno Unito 6.076
VN - Vietnam 6.007
DE - Germania 3.799
IT - Italia 3.393
SE - Svezia 2.658
HK - Hong Kong 2.060
IN - India 1.463
RU - Federazione Russa 1.412
BR - Brasile 1.390
NL - Olanda 1.201
UA - Ucraina 1.147
FR - Francia 988
IE - Irlanda 935
KR - Corea 729
FI - Finlandia 514
ZA - Sudafrica 505
CI - Costa d'Avorio 457
EE - Estonia 412
TG - Togo 412
JP - Giappone 335
CH - Svizzera 328
SC - Seychelles 280
AR - Argentina 258
JO - Giordania 256
BG - Bulgaria 208
AT - Austria 192
CA - Canada 187
ID - Indonesia 154
ES - Italia 148
BE - Belgio 127
PL - Polonia 111
NG - Nigeria 106
IR - Iran 93
MX - Messico 89
EC - Ecuador 77
BD - Bangladesh 76
GR - Grecia 64
TR - Turchia 61
HR - Croazia 54
CL - Cile 51
AU - Australia 42
IQ - Iraq 42
CO - Colombia 40
PY - Paraguay 39
LB - Libano 32
CZ - Repubblica Ceca 27
LT - Lituania 26
RO - Romania 26
UZ - Uzbekistan 26
PK - Pakistan 25
PT - Portogallo 24
MA - Marocco 23
MY - Malesia 21
PE - Perù 20
VE - Venezuela 19
EG - Egitto 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 14
KE - Kenya 14
TN - Tunisia 13
DK - Danimarca 12
TW - Taiwan 12
PH - Filippine 11
UY - Uruguay 11
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
CR - Costa Rica 9
DO - Repubblica Dominicana 9
HU - Ungheria 9
A2 - ???statistics.table.value.countryCode.A2??? 8
GE - Georgia 8
NZ - Nuova Zelanda 8
IL - Israele 7
KZ - Kazakistan 7
MN - Mongolia 7
TH - Thailandia 7
AZ - Azerbaigian 6
BO - Bolivia 6
LK - Sri Lanka 6
MD - Moldavia 6
MK - Macedonia 6
AL - Albania 5
KG - Kirghizistan 5
KW - Kuwait 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
BJ - Benin 4
BY - Bielorussia 4
DZ - Algeria 4
PS - Palestinian Territory 4
AO - Angola 3
BN - Brunei Darussalam 3
CM - Camerun 3
GA - Gabon 3
HN - Honduras 3
JM - Giamaica 3
ME - Montenegro 3
Totale 90.294
Salva come PNG Salva come JPEG
Città #
Singapore 5.558
Southend 5.409
Fairfield 3.652
Ashburn 3.595
Houston 2.662
Chandler 2.521
Hong Kong 2.042
Hefei 1.682
Woodbridge 1.654
Wilmington 1.606
Seattle 1.573
Santa Clara 1.445
Princeton 1.323
Cambridge 1.287
Dong Ket 1.209
Beijing 1.126
Ann Arbor 959
Dublin 933
Boardman 883
Ho Chi Minh City 768
Jacksonville 718
Seoul 716
Kerkrade 648
Bologna 639
Hanoi 588
Westminster 526
Los Angeles 501
Frankfurt am Main 492
Nanjing 483
Abidjan 457
Padova 450
Dallas 443
Lomé 412
Berlin 407
Helsinki 395
Munich 358
New York 342
Tokyo 316
Jinan 294
Buffalo 289
Milan 288
Bern 286
Amman 254
Saint Petersburg 247
Redondo Beach 243
Shenyang 237
San Diego 220
Changsha 211
Turin 203
Sofia 196
Guangzhou 175
Hebei 168
Medford 161
São Paulo 161
Nanchang 160
Mülheim 157
Bremen 152
Bengaluru 151
Florence 145
Tianjin 141
Redmond 140
Shanghai 140
Nuremberg 130
Jiaxing 122
Zhengzhou 121
Des Moines 117
Chicago 111
Brussels 110
Dearborn 110
London 105
Yubileyny 99
Abeokuta 98
Redwood City 93
Vienna 93
Tongling 91
Da Nang 89
Falkenstein 87
Hangzhou 87
Phoenix 84
Norwalk 83
Rome 83
Haiphong 81
Jakarta 81
Falls Church 80
Mahé 78
Hamburg 75
Olalla 75
Toronto 75
Lappeenranta 65
Taizhou 65
Kuban 63
Brooklyn 62
Haikou 59
Taiyuan 57
Warsaw 57
Bühl 54
The Dalles 53
Johannesburg 52
Biên Hòa 50
Kunming 50
Totale 58.742
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.297
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. 1.193
Merkel cell carcinoma: a prompt diagnosis to increase survival 626
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 464
Radiomic Features from Post-Operative 18F-FDG PET/CT and CT Imaging Associated with Locally Recurrent Rectal Cancer: Preliminary Findings 308
18F-FDG PET early after radiotherapy in lymphoma patients. 292
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. 283
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 274
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 270
11-C-choline PET/CT imaging for localization of recurrent prostate cancer 263
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? 246
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 246
F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease 243
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence 240
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 236
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 234
11 C-CHOLINE-PET/CT FOR PREOPERATIVE N-STAGING IN HIGH RISK PROSTATE CANCER 230
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 227
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 226
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. 226
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 226
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence 221
Does technetium-99m diethylenetriaminepentaacetate clearance predict the clinical course of idiopathic pulmonary fibrosis? 221
18F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art 218
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 217
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. 216
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 211
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 211
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma 211
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 209
An Apparent Diffusion Coefficient-based machine learning model can improve Prostate Cancer detection in the grey area of the PI-RADS 3 category: a single-centre experience 208
18 F-FDG PET in malignant lymphoma: significance of positive findings 208
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 208
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 207
Accuracy of 18f-facbc (anti1-amino-3-18f-fluorocyclobutane-1-carboxylic acid) in prostate cancer relapse: Results of a prospective trial 207
F-18-NaF PET/CT: EANM procedure guidelines for bone imaging (vol 2, pg 1767, 2015). 204
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 202
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 201
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging 200
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 199
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 198
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy 198
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 197
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 196
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 196
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion 195
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. 195
18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 195
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer 195
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 194
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 193
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial 193
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 193
Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. 192
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study. 192
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 192
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 190
A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? 188
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 187
11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard 187
11C-COLINA-PET/CT NEL N-STAGING PREOPERATORIO DEL CARCINOMA PROSTATICO AD ALTO RISCHIO 186
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. 186
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. 185
11C-CHOLINE PET/TC imaging for localization of recurrent prostate cancer 185
Biopathological factors and tumor response in patients with rectal cancer treated with neoadjuvant radiochemotherapy: early results of the phase II Bologna study. 184
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 184
68Ga-PSMA PET/CT for restaging prostate cancer after definitive therapy: Results of a prospective single-center trial 184
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 184
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome. 183
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 182
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 182
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 182
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 182
18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study 181
Complete pathological response after chemo-radiation in anaplastic thyroid cancer: A report of two cases 181
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 181
11C-Choline PET/CT for Restaging of Bladder Cancer 181
Accuracy of 18F-FDG-PET/CT in the pre surgical staging of ovarian cancer. 180
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 180
Radiolabelled peptides in diagnosis and therapy: an introduction. 178
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma 178
Prediction of 89Zr production using the Monte Carlo code FLUKA 178
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 178
Prediction of Overall Survival in Cervical Cancer Patients Using PET/CT Radiomic Features 177
18F-FDG PET/CT detects systemic involvement in Sarcoidosis 177
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 177
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. 177
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 176
Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach 175
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 174
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity 174
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 173
Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease 173
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 172
Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters. 172
How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery? 172
Compendio di Medicina Nucleare 171
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 171
Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma. 170
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 170
Totale 22.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.507 0 0 0 0 0 451 149 613 939 414 467 2.474
2021/202212.430 2.645 405 633 902 1.039 588 236 839 407 604 2.380 1.752
2022/202312.031 1.247 1.758 718 1.485 764 861 358 652 2.105 435 960 688
2023/20243.702 369 602 216 316 266 706 213 255 162 269 162 166
2024/202515.444 543 2.289 1.370 1.058 2.410 890 1.285 479 325 925 843 3.027
2025/202620.253 3.222 4.032 3.525 2.732 3.975 2.767 0 0 0 0 0 0
Totale 92.085